Select Medical (SEM) Competitors

$27.85
+0.44 (+1.61%)
(As of 01:40 PM ET)

SEM vs. EHC, IRTC, INSM, PACS, PBH, RARE, IBRX, CBAY, NVST, and AXSM

Should you be buying Select Medical stock or one of its competitors? The main competitors of Select Medical include Encompass Health (EHC), iRhythm Technologies (IRTC), Insmed (INSM), PACS Group (PACS), Prestige Consumer Healthcare (PBH), Ultragenyx Pharmaceutical (RARE), ImmunityBio (IBRX), CymaBay Therapeutics (CBAY), Envista (NVST), and Axsome Therapeutics (AXSM). These companies are all part of the "medical" sector.

Select Medical vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, valuation, profitability and risk.

In the previous week, Encompass Health had 30 more articles in the media than Select Medical. MarketBeat recorded 36 mentions for Encompass Health and 6 mentions for Select Medical. Encompass Health's average media sentiment score of 0.69 beat Select Medical's score of 0.25 indicating that Encompass Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Encompass Health
11 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Select Medical has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500.

Encompass Health received 161 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.70% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
326
57.70%
Underperform Votes
239
42.30%
Encompass HealthOutperform Votes
487
71.83%
Underperform Votes
191
28.17%

Encompass Health has a net margin of 7.60% compared to Select Medical's net margin of 3.65%. Encompass Health's return on equity of 18.01% beat Select Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical3.65% 16.93% 3.30%
Encompass Health 7.60%18.01%6.55%

Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.66B0.54$243.49M$1.9114.60
Encompass Health$4.80B1.75$352M$3.7022.62

89.5% of Select Medical shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 17.5% of Select Medical shares are held by company insiders. Comparatively, 2.1% of Encompass Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.8%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 26.2% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Select Medical currently has a consensus target price of $34.40, indicating a potential upside of 24.01%. Encompass Health has a consensus target price of $88.13, indicating a potential upside of 5.67%. Given Select Medical's higher possible upside, equities analysts plainly believe Select Medical is more favorable than Encompass Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Summary

Encompass Health beats Select Medical on 16 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEM vs. The Competition

MetricSelect MedicalHospitals IndustryMedical SectorNYSE Exchange
Market Cap$3.58B$4.23B$4.73B$17.42B
Dividend Yield1.82%1.28%5.32%3.54%
P/E Ratio14.609.16170.3021.76
Price / Sales0.540.892,356.4410.48
Price / Cash7.568.6631.3615.39
Price / Book2.312.304.674.92
Net Income$243.49M$178.36M$99.62M$961.15M
7 Day Performance2.01%1.87%112.51%1.95%
1 Month Performance-7.53%-5.59%105.64%-3.09%
1 Year Performance-8.59%-5.23%137.27%95.51%

Select Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EHC
Encompass Health
4.813 of 5 stars
$82.46
+2.7%
$83.22
+0.9%
+28.6%$8.26B$4.80B23.7638,000Earnings Report
Analyst Report
Short Interest ↓
Analyst Revision
IRTC
iRhythm Technologies
0.4986 of 5 stars
$116.34
+2.4%
$135.11
+16.1%
-14.8%$3.62B$492.68M-28.732,000Upcoming Earnings
Short Interest ↑
INSM
Insmed
4.309 of 5 stars
$25.27
+4.8%
$44.64
+76.6%
+27.2%$3.58B$305.21M-4.73373Upcoming Earnings
Positive News
PACS
PACS Group
0 of 5 stars
$24.37
+5.8%
N/AN/A$3.66BN/A0.0032,433
PBH
Prestige Consumer Healthcare
3.9288 of 5 stars
$71.23
+2.0%
$110.00
+54.4%
+14.5%$3.54B$1.13B-43.43560Upcoming Earnings
Positive News
RARE
Ultragenyx Pharmaceutical
4.3671 of 5 stars
$45.11
+3.3%
$90.33
+100.3%
+1.3%$3.71B$434.25M-5.421,276Upcoming Earnings
IBRX
ImmunityBio
0.1564 of 5 stars
$5.49
+11.1%
$5.00
-8.9%
+162.5%$3.72B$620,000.00-4.73628Analyst Report
Gap Up
High Trading Volume
CBAY
CymaBay Therapeutics
1.0285 of 5 stars
$32.48
flat
$28.65
-11.8%
+201.9%$3.73B$31.07M-33.48101Analyst Report
NVST
Envista
4.5817 of 5 stars
$20.23
+0.6%
$29.60
+46.4%
-47.0%$3.48B$2.57B-33.1612,800Upcoming Earnings
Analyst Downgrade
AXSM
Axsome Therapeutics
4.5589 of 5 stars
$73.08
+2.8%
$119.67
+63.7%
+0.3%$3.46B$270.60M-14.05545Upcoming Earnings
Analyst Upgrade
News Coverage
Gap Up

Related Companies and Tools

This page (NYSE:SEM) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners